HIGHLIGHTS
- who: Zhengping Che from the University, China have published the Article: Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases, in the Journal: (JOURNAL)
- future: More in-depth mechanistic basic and preclinical studies clinical trials and long-term follow-up are required to establish optimal treatment modalities for MSC based therapy of IBDs.
SUMMARY
In recent years, mesenchymal stem_cells (MSCs)-based therapy has emerged as a promising strategy for the treatment of IBDs due to their potent immuno-modulatory and tissuerepair functions. In response to different . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.